Burcu Gündoğdu Öztürk

Burcu Gündoğdu Öztürk

Auto-generated profile, based on publicly available information

Burcu Gündoğdu Öztürk

Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
BGBurcu Gündoğdu
Burcu Gündoğdu
ÖTÖmer Lütfi Tapisiz
Ömer Lütfi Tapisiz
BDBerna Di̇lBaz
Berna Di̇lBaz
SMSerkan Barış MÜLAZIMOĞLU
Serkan Barış MÜLAZIMOĞLU
KMKamil Hakan Müftüoğlu
Kamil Hakan Müftüoğlu
ÜGÜmit Göktolga
Ümit Göktolga
Background/aim: To evaluate the effects of hysterectomy on rat ovaries and the possible protective role of peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist-rosiglitazone against ovarian reserve decrement. Materials and methods: Forty-five adult Wistar albino rats were randomly divided into three groups. Hysterectomy was performed (n = 15) in group 1 [H]; 1 mg/kg/day PPAR-gamma agonist/rosiglitazone was used for 50 days after hysterectomy (n = 15) in group 2 [H + R]; a sham operation was performed (n = 15) in group 3 [control, C]. Blood samples were collected for anti-Mullerian hormone (AMH) evaluation in all groups and simultaneous ovarian Doppler examination was performed in [H] and [H + R] groups before and after (50 days) hysterectomy. All animals were sacrificed to obtain ovaries for histological examination. Results: AMH levels were found to be significantly decreased at postoperative day 50 in all groups (P < 0.05). Histopathologic analysis showed that primary, preantral, and antral follicle counts were significantly higher in the [H] group as compared to the [C] and [H + R] groups (P < 0.05). There was no significant difference between the [C] and [H + R] groups in terms of follicle numbers (P > 0.05). In the ovarian Doppler blood flow analysis, all parameters were significantly decreased in group [H] (P < 0.05), but not in the [H + R] group (P > 0.05) on postoperative day 50. Conclusion: Hysterectomy affects the histopathological structure of rat ovaries and PPAR-gamma agonist-rosiglitazone improves the ovarian Doppler blood flow parameters.

1 December 2025 in Gynecology and Pelvic Medicine
Verified
Journal Article
Open access
FKFulya Kayikcioglu
Fulya Kayikcioglu
BOBurcu Gundogdu Ozturk
Burcu Gundogdu Ozturk
Uterine leiomyomas are the most common benign tumors of the female genital tract, affecting approximately 20–40% of women of reproductive age. Clinically, they may present with heavy menstrual bleeding, pelvic pain, pressure symptoms, and infertility. There are different treatment modalities depending on the patient’s age and expectations, uterine size, the size and localization of the myoma(s), etc. Myomectomy is a key surgical option, particularly for patients who wish to preserve fertility or maintain the uterus. Although minimally invasive approaches are increasingly used, open (abdominal) myomectomy remains a preferred technique for large, numerous, or deeply located fibroids. The aim of this article is to investigate in which patients open abdominal myomectomy should be preferred. In this context, we will discuss the advantages and disadvantages of the surgical treatment methods of fibroids in patients. PubMed, Web of Science, and Google Scholar were queried using pertinent keywords to retrieve relevant studies with a particular focus on open abdominal myomectomy, mini-laparotomy, laparoscopic and hysteroscopic myomectomy for uterine fibroids. Myomectomy with laparotomy seems to be more appropriate in the presence of an intramural myoma >10–12 cm in size or multiple myomas (≥4) at different sites in the uterus, requiring numerous incisions. Treatment preferences depend on the patient’s age and desire to preserve fertility, as well as the clinical presentation of the myoma such as the size, number and location of fibroids, and also the surgical experience of the gynecologist.

1 August 2026 in The European Research Journal
Verified
Journal Article
Open access
PDF file
EÖEmel Özalp
Emel Özalp
DEDeniz Erbaş
Deniz Erbaş
İKİlknur Alkan Kuşabbi
İlknur Alkan Kuşabbi
TATürkan Dikici Aktaş
Türkan Dikici Aktaş
BÖBurcu Gündoğdu Öztürk
Burcu Gündoğdu Öztürk
IKInci Kahyaoglu
Inci Kahyaoglu
Objective: Follicular-fluid biomarkers may characterize the peri-oocyte microenvironment, but their incremental value beyond established ovarian-reserve tests is uncertain. Methods: This prospective observational study included 42 women aged 18–40 years undergoing in vitro fertilization at Ankara Etlik City Hospital, including 21 with diminished ovarian reserve and 21 with unexplained infertility. Follicular-fluid anti-Müllerian hormone was measured by electrochemiluminescence immunoassay and leptin by enzyme-linked immunosorbent assay. Results: Pregnancy analyses used complete-case data from 22 of 25 women who underwent embryo transfer. Follicular-fluid anti-Müllerian hormone was lower in the diminished ovarian reserve group [1.13 (0.94–1.45) versus 3.40 (2.69–5.93) nanograms per milliliter; P<0.001], whereas leptin was similar (1243.73±340.50 versus 1265.78±233.35 picograms per milliliter; P=0.808). Women with diminished ovarian reserve had fewer retrieved, mature, and fertilized oocytes. Fourteen clinical pregnancies occurred among the 22 transfers with complete follow-up. Serum and follicular-fluid anti-Müllerian hormone and antral follicle count were higher among women with clinical pregnancy, but exploratory penalized regression did not identify anti-Müllerian hormone as an independent predictor. Leptin was not associated with infertility group or clinical pregnancy. Conclusion: Follicular-fluid anti-Müllerian hormone appears to reflect ovarian-reserve phenotype and granulosa-cell activity rather than provide proven incremental clinical value over serum anti-Müllerian hormone and antral follicle count. Larger follicle-matched studies with live-birth endpoints are required before either marker is used in routine clinical decision-making.

29 March 2022 in Türk Kadın Sağlığı ve Neonatoloji Dergisi
Verified
Journal Article
Closed access
PDF file
AAAlperen Aksan
Alperen Aksan
BÖBurcu Gündoğdu Öztürk
Burcu Gündoğdu Öztürk
BDBerna Di̇lbaz
Berna Di̇lbaz
Endometrial stromal sarcoma (ESS) is a rare malignant tumour of the uterus that usually occurs in perimenopausal women. Such a case was a hospitalized 42-year-old woman with acute heavy vaginal bleeding and severe anaemia. The patient refused to have a gynaecological examination and endometrial sampling. However, during the transabdominal ultrasonographic evaluation, an intramural submucous mass of 9 cm × 6 cm was detected in the fundal area of the uterus. The diagnosis of ESS was discovered unexpectedly by examining a frozen section of the tumour that was thought to be leiomyoma preoperatively. After intraoperative consultation with the Gynaecologic Oncology Department, total hysterectomy and bilateral salpingectomy were performed. Once the final pathological report was presented, the patient was recommended to have bilateral oophorectomy in order to proceed with the treatment.